Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Doxorubicin (as part of multi-agent chemotherapy)
Treatment for Hepatoblastoma
Typical Dosage: Various regimens, e.g., 30-60 mg/m2 per cycle
Effectiveness
75%
Safety Score
25%
Clinical Trials
200
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
Various regimens, e.g., 30-60 mg/m2 per cycle
Time to Effect
weeks
Treatment Duration
Part of a 4-6 month regimen
Evidence Quality
HIGHConfidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$2,000
Monitoring:$5,000
Side Effect Mgmt:$10,000
Total Annual:$17,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODQALYs Gained
15
Outcome-Based Costs
Cost per Responder
$24,285.71
Cost per Remission
$24,285.71
Doxorubicin (as part of multi-agent chemotherapy) Outcomes
for Hepatoblastoma
Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+70%
Remission Rate
+70%
Common Side Effects
Myelosuppression
+85%
Nausea and vomiting
+80%
Hair loss
+95%
Cardiotoxicity (cumulative dose)
+20%
Mucositis
+50%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov